Shares of select information technology (IT) and pharmaceutical companies are trading higher in otherwise weak market on defensive buying.
Sun Pharma, Lupin, GlaxoSmithKline Pharmaceuticals and Dr Reddy’s Laboratories from pharmaceuticals and HCL Technologies, Tech Mahindra, Wipro and MindTree from IT sector are up 1-3% on BSE.
As the central bank increased repo rate, the investors shifted their focus towards defensive stocks from interest rate-sensitives. The stocks belonging to the IT and pharmaceutical sectors trading higher, cyclical stocks lost significantly. Defensive stocks have historically done well during market corrections.
The Reserve Bank of India (RBI) today raised the repo rate by 25 basis points to 7.50% cent in a bid to check inflation.
Among the individual stocks, Dr Reddy's Laboratories hits a record high of Rs 2,402 in intra-day trade on BSE. The pharma stock has gained 8% in past three days after the company secured the approval of the US Food and Drug Administration (USFDA) to launch injectible medicine azacitidine, which is used in the treatment of bone marrow cancer and blood cell disorders.
Elder Pharma, Dishman Pharma and Ajanta Pharma from mid-cap space are up 1-5%.
On the other hand, shares of rate sensitive sectors such as real estate, infrastructure, automobiles and banking are down up to 12% amid concerns that hardening interest rates will hit demand for new loans, housing and vehicles
Sun Pharma, Lupin, GlaxoSmithKline Pharmaceuticals and Dr Reddy’s Laboratories from pharmaceuticals and HCL Technologies, Tech Mahindra, Wipro and MindTree from IT sector are up 1-3% on BSE.
As the central bank increased repo rate, the investors shifted their focus towards defensive stocks from interest rate-sensitives. The stocks belonging to the IT and pharmaceutical sectors trading higher, cyclical stocks lost significantly. Defensive stocks have historically done well during market corrections.
The Reserve Bank of India (RBI) today raised the repo rate by 25 basis points to 7.50% cent in a bid to check inflation.
Among the individual stocks, Dr Reddy's Laboratories hits a record high of Rs 2,402 in intra-day trade on BSE. The pharma stock has gained 8% in past three days after the company secured the approval of the US Food and Drug Administration (USFDA) to launch injectible medicine azacitidine, which is used in the treatment of bone marrow cancer and blood cell disorders.
Elder Pharma, Dishman Pharma and Ajanta Pharma from mid-cap space are up 1-5%.
On the other hand, shares of rate sensitive sectors such as real estate, infrastructure, automobiles and banking are down up to 12% amid concerns that hardening interest rates will hit demand for new loans, housing and vehicles
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%